Mohini Ranganathan

Blunted Psychotomimetic and Amnestic Effects of Δ-9-Tetrahydrocannabinol in Frequent Users of Cannabis

Deepak Cyril D’Souza, Mohini Ranganathan, Gabriel Braley et al. · Neuropsychopharmacology · 2008 · 261 citations

Medicine, Neuroscience, Pharmacology +14

The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial

Douglas L. Boggs, Toral Surti, Aarti Gupta et al. · Psychopharmacology · 2018 · 236 citations

Medicine, Pharmacology, Psychiatry +11

Rapid Changes in Cannabinoid 1 Receptor Availability in Cannabis-Dependent Male Subjects After Abstinence From Cannabis

Deepak Cyril D’Souza, Jose Cortes-Briones, Mohini Ranganathan et al. · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · 2015 · 210 citations

Medicine, Pharmacology, Psychiatry +11

Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial

Deepak Cyril D’Souza, Jose Cortes-Briones, Gina Creatura et al. · The Lancet Psychiatry · 2018 · 192 citations

Medicine, Pharmacology, Pharmacotherapy +15

Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder

David W. Oslin, Kevin G. Lynch, Mei‐Chiung Shih et al. · JAMA · 2022 · 184 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +17